Contact Us Menu

Intravitreal Anti-Vascular Endothelial Growth Factor Cost Savings Achievable with Increased Bevacizumab Reimbursement and Utilization

Authors: Glasser DB, Parikh R, Lum F, Williams GA
June 2020
Back